PMID- 20361945 OWN - NLM STAT- MEDLINE DCOM- 20100719 LR - 20220330 IS - 1873-2968 (Electronic) IS - 0006-2952 (Linking) VI - 80 IP - 5 DP - 2010 Sep 1 TI - Notch signaling: emerging molecular targets for cancer therapy. PG - 690-701 LID - 10.1016/j.bcp.2010.03.026 [doi] AB - The Notch signaling pathway is a highly conserved developmental pathway, which plays a critical role in cell-fate decision, tissue patterning and morphogenesis. There is increasing evidence that this pathway is dysregulated in a variety of malignancies, and can behave as either an oncogene or a tumor suppressor depending upon cell context. This review highlights the current evidence for aberration of the Notch signaling pathway in a wide range of tumors from hematological cancers, such as leukemia and lymphoma through to skin, breast, lung, pancreas, colon and brain tumors. It proposes that the Notch signaling pathway may represent novel therapeutic targets and will be a welcome asset to the cancer therapeutic arena. CI - Copyright 2010 Elsevier Inc. All rights reserved. FAU - Yin, Ling AU - Yin L AD - Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, United States. FAU - Velazquez, Omaida C AU - Velazquez OC FAU - Liu, Zhao-Jun AU - Liu ZJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20100331 PL - England TA - Biochem Pharmacol JT - Biochemical pharmacology JID - 0101032 RN - 0 (Antineoplastic Agents) RN - 0 (Receptors, Notch) SB - IM MH - Antineoplastic Agents/pharmacology/*therapeutic use MH - Humans MH - Neoplasms/*drug therapy/metabolism MH - Receptors, Notch/drug effects/*metabolism MH - *Signal Transduction RF - 158 EDAT- 2010/04/07 06:00 MHDA- 2010/07/20 06:00 CRDT- 2010/04/06 06:00 PHST- 2010/01/28 00:00 [received] PHST- 2010/03/23 00:00 [revised] PHST- 2010/03/24 00:00 [accepted] PHST- 2010/04/06 06:00 [entrez] PHST- 2010/04/07 06:00 [pubmed] PHST- 2010/07/20 06:00 [medline] AID - S0006-2952(10)00214-5 [pii] AID - 10.1016/j.bcp.2010.03.026 [doi] PST - ppublish SO - Biochem Pharmacol. 2010 Sep 1;80(5):690-701. doi: 10.1016/j.bcp.2010.03.026. Epub 2010 Mar 31.